Theraclion And Furui Medical Form JV To Market HIFU Surgical Device In China
Theraclion of France formed a China joint venture with Inner Mongolia Furui Medical Science to market Theraclion's HIFU surgery device. The Echopulse® is a non-invasive medical device employing ultrasound-guided high-intensity focused ultrasound (HIFU) to treat non-cancerous tumors -- breast fibroadenoma and benign thyroid nodules -- in an out-patient procedure. The JV, which will be based in Shenzhen, will be 56% owned by Theraclion China. Furui will own the rest.